Ameliorative effects of gut microbial metabolite urolithin a on pancreatic diseases
Urolithin A (Uro A) is a dietary metabolite of the intestinal microbiota following the ingestion
of plant-based food ingredients ellagitannins and ellagic acid in mammals. Accumulating …
of plant-based food ingredients ellagitannins and ellagic acid in mammals. Accumulating …
Acute and chronic pancreatitis disease prevalence, classification, and comorbidities: a cohort study of the UK BioBank
DM Spagnolo, PJ Greer, CS Ohlsen… - Clinical and …, 2022 - journals.lww.com
METHODS: A pancreatitis cohort of more than 4,200 patients and 24,000 controls were
identified in the UK BioBank (UKBB) consortium. A descriptive analysis was completed …
identified in the UK BioBank (UKBB) consortium. A descriptive analysis was completed …
Chronic pancreatitis and cancer risk in a matched cohort study using national claims data in South Korea
This study aimed to examine the association between chronic pancreatitis (CP) and cancer
incidence and mortality among the Korean population. Based on a cancer-free cohort of …
incidence and mortality among the Korean population. Based on a cancer-free cohort of …
[HTML][HTML] Assessment of pain associated with chronic pancreatitis: An international consensus guideline
AM Drewes, CL van Veldhuisen, MD Bellin… - Pancreatology, 2021 - Elsevier
Pain is the most common symptom in chronic pancreatitis (CP) with a major impact on
quality of life. Few validated questionnaires to assess pain in CP exist, and the lack of …
quality of life. Few validated questionnaires to assess pain in CP exist, and the lack of …
Catechin hydrate ameliorates cerulein‑induced chronic pancreatitis via the inactivation of TGF‑β/Smad2 signaling
B Kweon, DU Kim, JY Oh… - Molecular Medicine …, 2023 - spandidos-publications.com
Chronic pancreatitis (CP) is a pancreatic inflammatory disease associated with histological
changes, including fibrosis, acinar cell loss and immune cell infiltration, and leads to …
changes, including fibrosis, acinar cell loss and immune cell infiltration, and leads to …
[HTML][HTML] Incidence, prevalence, and comorbidities of chronic pancreatitis: A 7-year population-based study
QY Cai, K Tan, XL Zhang, X Han, JP Pan… - World Journal of …, 2023 - ncbi.nlm.nih.gov
BACKGROUND Chronic pancreatitis (CP) is a fibroinflammatory syndrome leading to
reduced quality of life and shortened life expectancy. Population-based estimates of the …
reduced quality of life and shortened life expectancy. Population-based estimates of the …
Metformin treatment is associated with reduced risk of hypoglycaemia, major adverse cardiovascular events, and all-cause mortality in patients with post-pancreatitis …
L Davidsen, MH Jensen, ME Cook… - European Journal of …, 2024 - academic.oup.com
Objective Post-pancreatitis diabetes mellitus (PPDM) is a frequent complication of
pancreatitis and is associated with an increased risk of adverse outcomes. Metformin is …
pancreatitis and is associated with an increased risk of adverse outcomes. Metformin is …
Disorders of the Pancreas
JC McDougal, ND Dharmadhikari… - Primary Care: Clinics …, 2023 - primarycare.theclinics.com
The pancreas is an essential organ which lies across the posterior abdominal wall between
the duodenum and spleen. Owing to its dual exocrine and endocrine function, it plays a vital …
the duodenum and spleen. Owing to its dual exocrine and endocrine function, it plays a vital …
Glucose-lowering therapy in patients with postpancreatitis diabetes mellitus: a nationwide population-based cohort study
R Viggers, MH Jensen, HVB Laursen… - Diabetes …, 2021 - Am Diabetes Assoc
OBJECTIVE Postpancreatitis diabetes mellitus (PPDM) is a type of secondary diabetes that
requires special considerations for management. The main objective was to examine …
requires special considerations for management. The main objective was to examine …
High-mobility group box 1 fragment ameliorates chronic pancreatitis induced by caerulein in mice
D Hokkoku, K Sasaki, S Kobayashi, T Shimbo… - Journal of …, 2024 - Springer
Background Chronic pancreatitis (CP) is a progressive disease characterized by pancreatic
fibrosis for which effective treatment options are lacking. Mesenchymal stem cells (MSCs) …
fibrosis for which effective treatment options are lacking. Mesenchymal stem cells (MSCs) …